Business Wire

ReSound® Brings Industry-Leading Hearing Aid Portfolio to EUHA 2015

7.10.2015 14:00 | Business Wire

Del

ReSound is pleased to return to EUHA’s 60th International Congress of Hearing Aid Acousticians next week in Nuremberg, Germany, to showcase the industry’s most comprehensive portfolio of hearing solutions. ReSound continues to bring consumers the most innovative solutions, superior sound quality, and connectivity to make life sound better for people living with hearing loss, demonstrating its continued leadership in the industry.

During the conference, ReSound will give interactive demonstrations of its complete lineup of Smart Hearing aids, including ReSound LiNX2™, the world’s first full family of Made for iPhone® hearing aids. This innovation builds on ReSound’s industry-leading technologies in all areas of Smart Hearing (audiology, connectivity, design, and apps), and on the fourth generation of GN ReSound’s proprietary 2.4 GHz wireless platform. ReSound will also showcase the world’s smartest super power hearing aid, ReSound ENZO™, for people with severe to profound hearing loss.

ReSound’s Smart Hearing aids lead the industry in connectivity, allowing users to stream sounds, including phone calls and music, directly to their hearing aids without the use of an intermediary device. Innovative technologies give wearers the most natural hearing experience possible, including Spatial Sense™, which gives wearers a natural ability to focus on conversation while maintaining a sense of where sounds are coming from. Users also have the freedom to personalize their hearing experience through the ReSound Smart™ app, available for iOS devices, including iPhone and Apple Watch, and several Android models.

Very recently, ReSound celebrated the global launch of the ReSound Enya™ family of hearing aids, the first wireless hearing aid offered to wearers looking for a cost-friendly solution. ReSound Enya represents the company’s dedication to making the most innovative hearing solutions available to as many people as possible.

“This year during EUHA, we are proud to showcase a complete and diverse portfolio of Smart Hearing, featuring the industry’s first full family of Made for iPhone hearing aids for people looking to take control of their hearing loss,” said GN ReSound CEO Anders Hedegaard. “ReSound constantly strives to deliver the best sound quality and connectivity through innovative, wireless hearing aids, and we are excited to incorporate interactive demonstrations of these superior solutions at EUHA. We are dedicated to giving people an effortless hearing experience, so that they can focus on living richer and more active lives.”

Participants at EUHA this year can experience ReSound Smart Hearing through interactive demonstrations by visiting Hall 4a B05. GN ReSound will also be represented during EUHA by the Beltone and Interton brands in Hall 3a C12 of the conference. Beltone recently launched Beltone Ally™, bringing their comprehensive hearing solutions to lower price points. For additional information on ReSound’s Smart Hearing solutions, consumers can visit www.resound.com.

About GN ReSound

GN ReSound is a leading international developer and manufacturer of advanced and innovative hearing healthcare solutions. It advances the wireless revolution with its unique 2.4 GHz and Bluetooth® Smart solutions. GN ReSound has reinvented the hearing system with its revolutionary ReSound LiNX2 hearing aids, and is driving and defining the future of hearing care. The company demonstrates its commitment to making life sound better through its research, insights and expertise in sound.

Contact information

GN ReSound
John Procter, +1-703-587-9967
Jprocter@Mcbeestrategic.Com
or
Jessica Larkin, +1-202-997-5582
Jlarkin@Mcbeestrategic.Com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Altierre Strengthens Executive Team in Europe With Hiring of Guillaume Vicot and Niclas Qvist22.8.2017 12:00Pressemelding

Altierre Corp., a provider of the world’s highest density, ultra-low energy, long-range wireless technology and applications for the Internet of Things (IoT) market, today announced two additions to its France-based European executive team. Guillaume Vicot has joined the company as General manager, Europe, Middle East and Asia (EMEA) and Niclas Qvist has joined as Vice President, Partner management & Marketing. Vicot joins Altierre’s management team after 17 successful years in the Auto-ID industry, barcode scanning and mobile computing. He most recently served as Vice President of sales, Western Europe, for PSC / Datalogic, leader in the bar code scanning industry, where he oversaw a team of more than 100 people and developed a tactical go-to-market strategy, achieving revenue well over US$100 million. “Guillaume has many top level strategic relationships with retailers

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15Pressemelding

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11Pressemelding

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom